Cotidié's fabrics are lightweight and moisture wicking — similar to exercise clothing — making the pieces conducive to the Houston heat and humidity. Lauren Marek/Cotidié

Houston is a humid subtropical climate — the majority of the year brings hot and sticky weather. Local entrepreneur Kristina Haag found herself struggling to find traditional clothing that is comfortable in the Texas heat, so she created it herself.

"With Cotidié, it is all about the functionality of the clothing," says Haag, founder of the clothing line Cotidié. "It is more traditional items, but the use of technical fabrics is our differentiating factor."

The online retailer, which launched in June 2019, offers pieces specifically tailored for women who are up against Houston's hot and muggy climate.

The line offers dresses, jackets, pants, skirts, and tops, ranging between $60 and $200 in price. The fabrics, sourced from Italy and Taiwan, provide breathable comfort, along with an elastic, structured fit for a more tailored look. All items are moisture wicking and machine washable. The line uses three different fabrics: LunAir, 88 percent polyester and 12 percent spandex; SolaSmooth, 73 percent nylon and 27 percent elastane; and StellaForm, 59 percent nylon and 41 percent elastane.

"Everything we use on the line is athletic technical fabric that you would typically find in workout attire, but I've repurposed these fabrics to use in a contemporary womenswear line," Haag tells InnovationMap. "I wanted to create a more foundational capsule clothing collection that women can draw their own inspiration from."

Haag, originally from Houston, studied history and business at Rice University before moving to London to attend the British School of Fashion. Following a few years of work at a London-based fashion PR firm, she returned to Texas. Haag was working a corporate job that required extensive job-site visits.

"I thought, how is there not more stylish women's clothing on the market that is comfortable and functional," says Haag.

The name Cotidié, which means "daily" or "every day," encompasses Haag's desire to create clothing that can be worn at work, for travel, on weekends, and more. Haag was determined to find comfortable professional clothing that held up in Houston's heat and humidity and created Cotidié to bridge the gap between technical performance wear and business attire, introducing a new kind of clothing for stylish women on the go.

Kristina Haag worked a corporate job that required her to run around Houston. She thought of her new fashion line out of wanting stylish clothes conducive to Houston's climate. Lauren Marek/Cotidié

Haag worked for over a year testing different fabrics and designing each piece to blend feminine style with technical performance. Haag works with Sew Pro Production, an apparel manufacturer based in Houston to develop the pieces.

For Cotidié's fall and winter line, which launched in October 2019, Haag adapted the pieces for cooler weather as the temperature shifts.

Haag plans to expand the marketing of Cotidié to a national scale in the next year. The company currently has two employees and has plans to begin fundraising efforts in 2020. The company currently ships internationally.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Axiom Space-tested cancer drug advances to clinical trials

mission critical

A cancer-fighting drug tested aboard several Axiom Space missions is moving forward to clinical trials.

Rebecsinib, which targets a cancer cloning and immune evasion gene, ADAR1, has received FDA approval to enter clinical trials under active Investigational New Drug (IND) status, according to a news release. The drug was tested aboard Axiom Mission 2 (Ax-2) and Axiom Mission 3 (Ax-3). It was developed by Aspera Biomedicine, led by Dr. Catriona Jamieson, director of the UC San Diego Sanford Stem Cell Institute (SSCI).

The San Diego-based Aspera team and Houston-based Axiom partnered to allow Rebecsinib to be tested in microgravity. Tumors have been shown to grow more rapidly in microgravity and even mimic how aggressive cancers can develop in patients.

“In terms of tumor growth, we see a doubling in growth of these little mini-tumors in just 10 days,” Jamieson explained in the release.

Rebecsinib took part in the patient-derived tumor organoid testing aboard the International Space Station. Similar testing is planned to continue on Axiom Station, the company's commercial space station that's currently under development.

Additionally, the drug will be tested aboard Ax-4 under its active IND status, which was targeted to launch June 25.

“We anticipate that this monumental mission will inform the expanded development of the first ADAR1 inhibitory cancer stem cell targeting drug for a broad array of cancers," Jamieson added.

According to Axiom, the milestone represents the potential for commercial space collaborations.

“We’re proud to work with Aspera Biomedicines and the UC San Diego Sanford Stem Cell Institute, as together we have achieved a historic milestone, and we’re even more excited for what’s to come,” Tejpaul Bhatia, the new CEO of Axiom Space, said in the release. “This is how we crack the code of the space economy – uniting public and private partners to turn microgravity into a launchpad for breakthroughs.”

Chevron enters the lithium market with major Texas land acquisition

to market

Chevron U.S.A., a subsidiary of Houston-based energy company Chevron, has taken its first big step toward establishing a commercial-scale lithium business.

Chevron acquired leaseholds totaling about 125,000 acres in Northeast Texas and southwest Arkansas from TerraVolta Resources and East Texas Natural Resources. The acreage contains a high amount of lithium, which Chevron plans to extract from brines produced from the subsurface.

Lithium-ion batteries are used in an array of technologies, such as smartwatches, e-bikes, pacemakers, and batteries for electric vehicles, according to Chevron. The International Energy Agency estimates lithium demand could grow more than 400 percent by 2040.

“This acquisition represents a strategic investment to support energy manufacturing and expand U.S.-based critical mineral supplies,” Jeff Gustavson, president of Chevron New Energies, said in a news release. “Establishing domestic and resilient lithium supply chains is essential not only to maintaining U.S. energy leadership but also to meeting the growing demand from customers.”

Rania Yacoub, corporate business development manager at Chevron New Energies, said that amid heightening demand, lithium is “one of the world’s most sought-after natural resources.”

“Chevron is looking to help meet that demand and drive U.S. energy competitiveness by sourcing lithium domestically,” Yacoub said.

---

This article originally appeared on EnergyCapital.